EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

What We Have Here Is a Failure to Communicate: Interleukin-12 / Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial Disease

Alicia Μ Johnston, Nicholas L Rider, Alexandra F Freeman, Steven M Holland, Jordan S Orange, Craig D Platt, Andrea Carlo Anglero, Michael Tsoulis, Daniel Zinn, Patrick Passarelli, Marcus Shaker

The Journal of Allergy and Clinical Immunology: In Practice · 2026-07 · 14 (7) · 1529-1539

DOI: 10.1016/j.jaip.2026.02.026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-07. Verfasst von Alicia Μ Johnston und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Boston Children's Hospital, Harvard Medical School, Boston, Mass. Hauptthemen laut MEDLINE: Interferon-gamma, Interleukin-12, Mycobacterium Infections, Immunologic Deficiency Syndromes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, Takeda Pharmaceutical Company, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mendelian susceptibility to mycobacterial disease (MSMD) is a rare group of immunodeficiencies with high mortality characterized by a failure of communication between phagocytic cells and their regulatory/support networks. The objective of this article was to review key aspects of MSMD management. A defective IL-12/IFN-γ circuit can result in overwhelming intracellular infection, leading to lymphadenopathy, organomegaly, and sepsis. In the setting of unexplained lymphadenopathy, early tissue and blood culture, with special attention to mycobacteria, is essential. If MSMD is suspected, genetic testing to assess for pathogenic variants affecting the IFN-γ/IL-12 signaling pathway is available. To date, at least 19 genes with hundreds of unique mutations have been identified; thus, genetic testing is essential to determine the specific defect and direct therapy. Multiple antibiotics, cytokine therapy in selected cases, and bone marrow transplantation should be considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon-gammaInterleukin-12Mycobacterium InfectionsImmunologic Deficiency SyndromesHumansGenetic Predisposition to DiseaseSignal TransductionAnimals

Stichwörter der Autor:innen

IFN-γIL-12ImmunodeficiencyLymphadenopathyMSMDMendelian susceptibility to mycobacterial disease

Substanzen

Interferon-gammaInterleukin-12

Autor:innen und Institutionen

  • Division of Infectious Diseases, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
  • Virginia Tech Carilion School of Medicine, Department of Health Systems & Implementation Science, Roanoke, Va; Carilion Clinic, Department of Pediatrics, Section of Allergy-Immunology, Roanoke, Va.
  • National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Children's Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa.
  • Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
  • Pediatric Infectious Disease, University of Pittsburgh Medical Center, Pittsburg, Pa.

Förderung

  • Intramural NIH HHS
  • Takeda Pharmaceutical Company
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases
  • LAM Therapeutics
  • Jeffrey Modell Foundation

Zitieren

APA

Johnston, A. Μ., Rider, N. L., Freeman, A. F., Holland, S. M., Orange, J. S., Platt, C. D., Anglero, A. C., Tsoulis, M., Zinn, D., Passarelli, P., & Shaker, M. (2026). What We Have Here Is a Failure to Communicate: Interleukin-12 / Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial Disease. The Journal of Allergy and Clinical Immunology: In Practice, 14(7), 1529-1539. https://doi.org/10.1016/j.jaip.2026.02.026

Vancouver

Johnston AΜ, Rider NL, Freeman AF, Holland SM, Orange JS, Platt CD, et al. What We Have Here Is a Failure to Communicate: Interleukin-12 / Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial Disease. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(7):1529-1539. doi:10.1016/j.jaip.2026.02.026

BibTeX
@article{Johnston2026,
  author = {Johnston, Alicia Μ and Rider, Nicholas L and Freeman, Alexandra F and Holland, Steven M and Orange, Jordan S and Platt, Craig D and Anglero, Andrea Carlo and Tsoulis, Michael and Zinn, Daniel and Passarelli, Patrick and Shaker, Marcus},
  title = {What We Have Here Is a Failure to Communicate: Interleukin-12 / Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial Disease},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2026},
  volume = {14},
  number = {7},
  pages = {1529--1539},
  doi = {10.1016/j.jaip.2026.02.026}
}
Kostenlos starten →